1. Zhao, Wei, Ma, Xiaozhou, Liu, Lina, Wang, Zuomin, Wu, Jie. 2019. SNHG20: A vital lncRNA in multiple human cancers. In Journal of cellular physiology, 234, 14519-14525. doi:10.1002/jcp.28143. https://pubmed.ncbi.nlm.nih.gov/30644099/
2. Xie, Zuozhong, Xiang, Hong, Li, Jingkun, Li, Wei, Tan, Guolin. 2022. SNHG20 promotes the development of laryngeal squamous cell carcinoma via miR-342-3p/MTDH axis. In Heliyon, 8, e10085. doi:10.1016/j.heliyon.2022.e10085. https://pubmed.ncbi.nlm.nih.gov/36033309/
3. Li, Y, Xu, J, Guo, Y-N, Yang, B-B. . LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140. In European review for medical and pharmacological sciences, 23, 3401-3409. doi:10.26355/eurrev_201904_17704. https://pubmed.ncbi.nlm.nih.gov/31081112/
4. Xu, Bin, Li, Chao, Yang, Bin, Wang, Lantian, Lu, Wenjie. 2023. LncRNA SNHG20 silencing inhibits hepatocellular carcinoma progression by sponging miR-5095 from MBD1. In American journal of translational research, 15, 4314-4331. doi:. https://pubmed.ncbi.nlm.nih.gov/37434830/
5. Xing, Xuefeng, An, Ming, Chen, Tonghua. 2021. LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer. In Genes & genomics, 43, 1095-1104. doi:10.1007/s13258-021-01138-4. https://pubmed.ncbi.nlm.nih.gov/34302635/
6. Wang, Chaoyu, Fu, Wen, Zhang, Youju, Xu, Qiuran, Tong, Xiangmin. 2024. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin. In Biology direct, 19, 47. doi:10.1186/s13062-024-00488-9. https://pubmed.ncbi.nlm.nih.gov/38886753/
7. Yang, Qi, Dong, Yu-Jie. 2021. LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis. In Journal of ovarian research, 14, 168. doi:10.1186/s13048-021-00889-8. https://pubmed.ncbi.nlm.nih.gov/34836544/
8. Wang, Z-X, Zhao, Y, Yu, Y, Cheng, K-P, Lin, F-W. . Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway. In European review for medical and pharmacological sciences, 24, 230-237. doi:10.26355/eurrev_202001_19915. https://pubmed.ncbi.nlm.nih.gov/31957836/
9. Gao, X F, He, H Q, Zhu, X B, Xie, S L, Cao, Y. 2019. LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway. In Neoplasma, 66, 532-542. doi:10.4149/neo_2018_180829N656. https://pubmed.ncbi.nlm.nih.gov/30943748/